Self-monitoring | Reported calorie intake | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Estimate | SE | df | t | p | Estimate | SE | df | t | p | |
Intercept | 0.66 | 0.16 | 315.5 | 4.09 | <0.001*** | 0.60 | 0.16 | 307.8 | 3.69 | <0.001*** |
Session number | –0.53 | 0.005 | 6685 | –104.78 | <0.001*** | –0.53 | 0.005 | 6658 | –95.04 | <0.001*** |
Discrepancy change | –0.88 | 0.46 | 93.65 | –1.91 | 0.06 | –0.67 | 0.35 | 175.9 | –1.92 | 0.06 |
Responder status | –3.25 | 0.29 | 429.7 | –14.55 | <0.001*** | –3.24 | 0.22 | 431.9 | –14.47 | <0.001*** |
Clinician-rated adherence | –0.48 | 0.04 | 6861 | –11.91 | <0.001*** | –0.45 | 0.04 | 6857 | –11.15 | <0.001*** |
Discrepancy change × session | 0.16 | 0.02 | 6651 | 8.94 | <0.001*** | 0.14 | 0.01 | 6608 | 9.78 | <0.001*** |
* p < 0.05. Discrepancy change scores were computed as the mean difference in discrepancy score from Sessions 1–10 to Sessions 11–20 for each subject and for each adherence measure. Mean change to self-monitoring adherence discrepancy from first to second half of treatment was 0.23 (SD = 0.82); mean change to reported calorie intake discrepancy from first to second half of treatment was 0.54 (SD = 1.18). All models included subject and clinician as a random effect, included a random slope and intercept for Discrepancy Score, used an unstructured covariance matrix and restricted maximum likelihood (REML) estimation. Satterwhaite approximations were used to estimate degrees of freedom and p-values. Session Number ranged from 1 to 20 and responder status was effect-coded (0 = non-responder at either Week 3 or Week 7, 1 = responder). For self-monitoring, AIC = 28543.6, BIC = 28632.73. For reported calorie intake, AIC = 28527.3, BIC = 28616.42.